click below
click below
Normal Size Small Size show me how
Microbio III
Vocabulary
| Question | Answer |
|---|---|
| develops rapidly, runs its course quickly | acute |
| ability to mount a defense against particular infectious agents by physiological responses specific to that agent | adaptive immunity |
| side effects of therapy that cause harm to the host, i.e. allergy or aplastic anemia | adverse effects |
| clumping together of the cells when antibodies react with antigens | agglutination |
| substance used to sterilize because of its ability to dissolve lipids & denature proteins | alcohol AKA phenols |
| agents that inhibit or kill bacterial microbes | antibacterial |
| a protein produced in response to an antigen; capable of binding specifically to that antigen | antibody AKA immunentoglobulin |
| agents that inhibit or kill fungi | antifungal |
| substance that the body identifies as foreign and mounts an immune response toward it | antigen AKA immunogen |
| chemical agent that can be safely used externally on tissues to destroy microorganisms or to inhibit their growth | antiseptic |
| agents that inhibit or kill viruses | antiviral |
| antigen presenting cells - cells with MHC II proteins on their surfaces | APC |
| genetically programmed cell death | apoptosis |
| vaccine containing live, weakened or dead organisms or their toxins to which an individual's body makes specific antibodies | artificial active immunity |
| when antibodies made by other hosts are introduced into a new host i.e. mother's milk or shots of gamma globulin | artificial passive immunity |
| some drugs are less effective when used in combination than when used alone | antagonism |
| consist of wax D & mycolic acids which are highly resistant to lysosomal (immunity) defenses of the body | acid fast cell walls |
| instrument for sterilization by means of heat under pressure | autoclave |
| immune disorder in which individuals are hypersensitive to antigens on cells of their own bodies | autoimmune disorder |
| microbes such as bacteria or viruses that manage to dodge a hosts immune system | avoid host defenses |
| lymphocyte produced and matures in bursal-equivalent tissue, it gives rise to antibody-producing plasma cells | B cell |
| agent that kills bacteria | bactericidal |
| agent that inhibits bacteria growth | bacteriostatic |
| when microbes such as bacteria & viruses that penetrate a body's first line of defenses, they | breach anatomical barriers |
| range of activity of an antimicrobial agent that attacks a wide variety of microorganisms | broad-spectrum agent |
| halogenic substance used to disinfect various items; kills bacteria and inactivates many viruses | chlorine |
| develops more slowly than acute and persists for a long, indeterminate period of time | chronic |
| short cellular projections used for movement that beat in coordinated waves | cilia |
| growth of microorganisms on epithelial surfaces such as skin or mucus membrance | colonization |
| 2 antibiotics administered simultaneously in order to exert an additive effect called synergism, sometimes causes antagonism | combinations of drugs |
| 2 or more drugs working together to attack different cell weaknesses | synergism |
| symbiotic relationship in which one organism benefits & the host neither benefits nor is harmed by the relationship | commensalism |
| infectious disease that can be spread from one host to another | communicable disease |
| innate, antimicrobial substances in body fluids, i.e. saliva, mucus, gastric juices & iron limitation mechanisms | chemical barriers |
| innate, cells that phagocytize invading microorganisms | cellular barriers |
| 2nd & 3rd LOD: set of more than 20 large regulatory proteins circulating in plasma & activated form a nonspecific defense mechanism against many different microorganisms | complement |
| soluble protein that has a specific role in host defenses | cytokine |
| drug that interferes with DNA synthesis, used to suppress the immune system & prevent rejection of transplants | cytotoxic drug |
| 1st line of defense: peptides in mucus & extracellular fluids are a group of molecules that kill pathogens creating pores in enemy cell membranes | defensins |
| person to person body contact | direct contact |
| method of sterilizing a loop | direct flaming |
| chemical agent used on inanimate objects to destroy microorganisms | disinfectant |
| disease that is constantly present in a specific population | endemic |
| a resistant, dormant structure formed inside some bacteria that can survive adverse conditions, i.e. Bacillus & Clostridium | endospores |
| a disease that has higher than normal incidence in a population over a relatively short period of time | epidemic |
| study of factors & mechanisms involved in the spread of disease within a population; studies distribution & frequency | epidemiology |
| innate form of defense; abnormally high body temp usually in order to kill invading agents or inactivate their toxic products | fever |
| nonliving substance capable of transmitting disease, such as clothing, dishes or paper | fomite |
| # of new cases of a particular disease per 100,000 pop. seen in a specific period of time | incidence |
| in the stages of infectious disease, the time between infectino & the appearance of signs & symptoms | incubation period |
| multiplication of a parasite organism, usually microscopic, within or upon the host's body | infection |
| innate body defense response to tissue damage caused by microbial infection, incl. reddening, swelling & increased temp | inflammation |
| immunity to infection that exists in an organism because of genetically determined characteristics | innate immunity |
| waterproofing protein found in epidermal cells | keratin |
| 1st LOD: protein in saliva, mucus, & milk that binds Fe inhibiting bacterial growth | lactoferrin |
| disease characterized by periods of inactivity either before symptoms appear or between attacks | latent disease |
| excess fluid & plasma proteins lost through capillary walls that is found in the lymphatic capillaries | lymph |
| encapsulated globular structures located along the routes of lymphatic vessels that help clear the lymph of microorganisms | lymph nodes |
| leukocyte (WBC) found in large #s in lymphoid tissue that contributes to SPECIFIC immunity | lymphocyte |
| 1st LOD: enzyme in tears, saliva, & mucus that cleaves covalent linkage between sugars in peptidoglycan; esp. effective against Gram+ | lysozyme |
| 2nd & 3rd LOD: destroy microorganisms & neutrophils that died after ingesting bacteria | macrophages |
| # of persons contracting a specific disease in relation to the total population (cases per 100,000) | morbidity rate |
| # of deaths from a specific disease in relation to the total population | mortality rate |
| 1st LOD: covering of tissues & organs exposed to body exterior & provide protection from injury & infectious agents | mucus membrane |
| form of symbiosis in which 2 organisms of different species live in a relationship that benefits both of them | mutualism |
| agents effective against a small # of organisms or a single taxonomic group | narrow-spectrum |
| Major Histocompatibility Complex- group of cell surface proteins that are essential to immune recognition reactions | MHC |
| innate mechanism using molecules such as interferon & complement to destroy or impede invading microbes | molecular defenses |
| 2nd LOD: polymorphonuclear, guard skin, blood & mucus membranes against infection; phagocytic; respond to tissue injury & infection | neutrophils |
| leukocytes that kill intracellular viruses, secreting cytotoxic proteins that infect & kill foreign cells; can be increased by cytokines & interferons | NK cells |
| microorganisms that live in or on the body but usually do not cause disease | normal microflora |
| alchohols that dissolve lipids & denature proteins so are used as disinfectants | phenolic compounds |
| to ingest and digest foreign particles by means of formation of vacuoles | phagocytize |
| cationic detergents which have 4 organic groups attached to a nitrogen atom (NH4) used to inactivate viruses | quats |
| ULQ; largest lymphatic organ; encapsulated, well supplied w/blood & lymphatic vessels; contains many phagocytes as well as B & T cells | spleen |
| 1st LOD: high salt content inhibits microbial growth | sweat |
| 1st LOD: protein that binds Fe that bacteria need thereby inhibiting bacterial growth | transferrin |
| the ability of a microorganism to remain unharmed by an antimicrobial agent | antimicrobial resistance |
| macrophage, dendritic or B cell that processes antigen fragments & presents peptide fragments from the antigen on its cell surface | antigen presenting cell |
| class of antibody that binds to receptors on basophils; responsible for allergic or immediate hypersensitivity reactions | IgE mediated |
| antigen-antibody complex that is normally eliminated by phagocytic cells | immune complex |
| "self" antigens, all cells except RBC's have them | MHC Class I |
| APC, MHC Class II carrying cell | macrophage |
| protective response of one's immune system to exposure of an infectious disease | naturally acquired active immunity |
| defense against specific disease acquired without the use of man-made products | naturally acquired adaptive immunity |
| when antibodies made by another individual are given to a host without man-made products, i.e. mother's milk | naturally acquired passive immunity |
| produced by general defenses, such as skin, lysozyme & complement, that protect against many different kinds of organisms (not just 1 or 2) | nonspecific immunity |
| an infection acquired in a hospital or medical facility | nosocomial infection |
| species of resident or transient microbiota that doesn't normally cause disease, but can do so under certain conditions | opportunistic pathogen |
| microorganisms are covered by antibodies rendering them more attractive to phagocytes & complement protein | opsonization |
| epidemic that has become worldwide | pandemic |
| relationship where one organism benefits & the other suffers | parasitism |
| organism capable of causing disease in its host | pathogen |
| mild heating to destroy pathogens & organisms that cause spoilage | pasteurization |
| site where microorganisms can gain access to body tissues: eyes, nose, mouth, broken skin, anus, urinary, vagina | portal of entry |
| # of people infected with a particular disease at any one time | prevalance |
| a genetic or developmental defect in which T or B cells are lacking or nonfunctional | primary immunodeficiency disease |
| site where microorganisms can persist & maintain their ability to infect | reservoir |
| result of damage to T or B cells after they developed normally | secondary immunodeficiency disease |
| ability of an antimicrobial agent to harm microbes without causing significant damage to the host | selective toxicity |
| ability of the immune system to mount a unique immune response to each antigen it encounters | specificity |
| the range of different microbes against which an antimicrobial agent is effective | spectrum of activity |
| 2 different kinds of organisms living together | symbiosis |
| CD4 | TH cell |
| CD8 | TC cell |
| structure or physiological characteristic that helps a pathogen cause infection or disease | virulent factor |
| degree of intensity of the disease produced by a pathogen | virulence |
| a cell actively metabolizing nutrients | vegetative cell |
| thriving populations of microflora compete with pathogenic organisms combating their growth | microbial antagonism |